These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 35145519)
21. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma. Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302 [TBL] [Abstract][Full Text] [Related]
22. Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma. Zhang L; Wang W; Wang R; Zhang N; Shang H; Bi Y; Chen D; Zhang C; Li L; Yin J; Zhang H; Cao Y Mol Ther; 2021 Feb; 29(2):744-761. PubMed ID: 33130310 [TBL] [Abstract][Full Text] [Related]
23. Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Chen R; Pan S; Ottenhof NA; de Wilde RF; Wolfgang CL; Lane Z; Post J; Bronner MP; Willmann JK; Maitra A; Brentnall TA Cancer Biol Ther; 2012 Aug; 13(10):899-907. PubMed ID: 22785208 [TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma. Nakagawa K; Akahori T; Nishiwada S; Nagai M; Nakamura K; Tanaka T; Tamamoto T; Ohbayashi C; Hasegawa M; Kichikawa K; Ikeda N; Sho M Langenbecks Arch Surg; 2018 Sep; 403(6):693-700. PubMed ID: 30218193 [TBL] [Abstract][Full Text] [Related]
25. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830 [TBL] [Abstract][Full Text] [Related]
26. Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival. Danilova L; Ho WJ; Zhu Q; Vithayathil T; De Jesus-Acosta A; Azad NS; Laheru DA; Fertig EJ; Anders R; Jaffee EM; Yarchoan M Cancer Immunol Res; 2019 Jun; 7(6):886-895. PubMed ID: 31043417 [TBL] [Abstract][Full Text] [Related]
27. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas. Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220 [TBL] [Abstract][Full Text] [Related]
28. Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients. Hiraoka N; Ino Y; Hori S; Yamazaki-Itoh R; Naito C; Shimasaki M; Esaki M; Nara S; Kishi Y; Shimada K; Nakamura N; Torigoe T; Heike Y Cancer Sci; 2020 Aug; 111(8):3057-3070. PubMed ID: 32495519 [TBL] [Abstract][Full Text] [Related]
29. CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinoma. Muth ST; Saung MT; Blair AB; Henderson MG; Thomas DL; Zheng L Cancer Lett; 2021 Feb; 499():99-108. PubMed ID: 33271264 [TBL] [Abstract][Full Text] [Related]
30. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer. Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281 [TBL] [Abstract][Full Text] [Related]
31. High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma. Zhou L; Lu J; Liang ZY; Zhou WX; Yuan D; Li BQ; You L; Guo JC; Zhao YP J Surg Oncol; 2018 Dec; 118(7):1115-1121. PubMed ID: 30261114 [TBL] [Abstract][Full Text] [Related]
32. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma. Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068 [TBL] [Abstract][Full Text] [Related]
33. The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis. Gao HL; Liu L; Qi ZH; Xu HX; Wang WQ; Wu CT; Zhang SR; Xu JZ; Ni QX; Yu XJ Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):95-100. PubMed ID: 29576277 [TBL] [Abstract][Full Text] [Related]
34. Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. Maréchal R; Bachet JB; Calomme A; Demetter P; Delpero JR; Svrcek M; Cros J; Bardier-Dupas A; Puleo F; Monges G; Hammel P; Louvet C; Paye F; Bachelier P; Le Treut YP; Vaillant JC; Sauvanet A; André T; Salmon I; Devière J; Emile JF; Van Laethem JL Clin Cancer Res; 2015 Mar; 21(5):1215-24. PubMed ID: 25552484 [TBL] [Abstract][Full Text] [Related]
35. A quantitative score of immune cell infiltration predicts the prognosis in pancreatic ductal adenocarcinoma. Chen ZG; Wang Y; Fong WP; Hu MT; Liang JY; Wang L; Li YH Int Immunopharmacol; 2021 Sep; 98():107890. PubMed ID: 34174701 [TBL] [Abstract][Full Text] [Related]
36. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal. Mundry CS; Eberle KC; Singh PK; Hollingsworth MA; Mehla K Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188387. PubMed ID: 32579889 [TBL] [Abstract][Full Text] [Related]
37. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models. Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718 [TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes. Zhao L; Zhao H; Yan H BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660 [TBL] [Abstract][Full Text] [Related]
39. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population. Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548 [TBL] [Abstract][Full Text] [Related]
40. Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma. Rowan DJ; Hartley CP; Aldakkak M; Christians KK; Evans DB; Tsai S; Hagen CE Ann Diagn Pathol; 2020 Jun; 46():151485. PubMed ID: 32172219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]